BSEBoard Meeting4d ago · 12 Oct 2026, 11:44 am
Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2026 ,inter alia, to consider and approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30 September 2026. Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ''''designated ....
Tatva Chintan Pharma Chem Ltd · 543321
✦ AI SummaryResults
Tatva Chintan Pharma Chem Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 19/10/2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30 September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 19.10.2026
Attachments (1)
📄pdf
Download →
08187155-d5fe-4478-a761-de6487ed06d5.pdf
View document text
Date: 12 October 2026 Ref. No.: TCPCL/SEC/2026-27/00050
The General Manager, The Manager,
Corporate relationship department, Listing department,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Fort, Bandra-Kurla Complex, Bandra(E),
Mumbai-400 001 Mumbai-400 051
Scrip Code: 543321 Scrip Symbol: TATVA
Subject: Intimation of Board Meeting to be held on Monday, 19.10.2026
Dear Sir/Madam,
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby
inform you that a meeting of the Board of Directors of Tatva Chintan Pharma Chem Limited
is scheduled to be held on Monday, 19 October 2026, inter-alia, to consider, approve and
take on record the Standalone and Consolidated Unaudited Financial Results of the
Company for the quarter and half year ended 30 September 2026.
Further, in accordance with the Company's Code of Conduct for Prohibition of Insider
Trading, the Company has intimated its ''designated persons'' regarding the closure of the
Trading Window for trading in the Company's equity shares from 01 October 2026 till the
expiry of 48 hours from the date the said financial results are made public.
The above information is also being made available on the website of the Company at
www.tatvachintan.com.
Kindly take the above intimation on your record and oblige.
Thanking you,
Yours faithfully,
For Tatva Chintan Pharma Chem Limited
Ishwar Nayi
Company Secretary and Compliance Officer
M. No.: A37444